UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - other
1673
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Compounds for Reversing the Adverse Effects of Early Life Adversity During Childhood (UCLA Case No. 2021-078)
Compositions and methods for diagnosing patients with a history of early-life adversity (ELA), and for preventing, treating, or reducing psychological distress in patients with a history of ELA. Contact UCLA Technology Development Group for more information.
Published: 11/25/2025
|
Inventor(s):
Arpana Church
Keywords(s):
Category(s):
Therapeutics > Psychiatry And Mental Health
RSA-Wearable Alertness Detecting Device (Case No. 2025-245)
Summary: UCLA researchers from the Department of Medicine-Pulmonary Disease have developed a novel wearable device to detect alertness and predict the onset of sleep for improved safety. Background: Hypersomnia and excessive daytime sleepiness (EDS) are both symptoms of a broad class of sleeping disorders including obstructive sleep apnea (OSA),...
Published: 11/25/2025
|
Inventor(s):
Ravi Aysola
Keywords(s):
Biomonitoring
,
Computer Monitor
,
continuous sleep monitoring
,
CPAP
,
Gene Block
,
non-invasive monitoring
,
patient outcome
,
Philips
,
public health monitoring
,
remote monitoring
,
remote patient analysis
,
remote patient monitoring (RPM)
,
Remote Sensing
,
sleep apnea
,
sleep monitoring
,
sleep monitoring and health
,
wearable
,
wearable electronics
,
wearable medical device
,
wearable medical devices
,
wearable sensors
,
wearable sensors for health
Category(s):
Medical Devices
,
Medical Devices > Monitoring And Recording Systems
,
Medical Devices > Hospital Systems
,
Electrical
,
Electrical > Sensors
,
Electrical > Flexible Electronics
,
Platforms
,
Software & Algorithms
,
Software & Algorithms > Digital Health
,
Software & Algorithms > Data Analytics
Thin Bilayer Paints to Enable Passive Daytime Radiative Cooling (Case No. 2026-014)
Intro Sentence: UCLA researchers in the Department of Materials Science and Engineering have formulated a novel bilayer coating that enables high-performance passive daytime radiative cooling. Background: Conventional technologies for cooling buildings are highly energy-intensive, consuming about 19% of U.S. residential electricity and contributing...
Published: 11/17/2025
|
Inventor(s):
Aaswath Raman
,
Aryan Zaveri
,
Justin Louie
Keywords(s):
advanced thermal control materials
,
advanced thermal paint
,
alternative cooling
,
background radiation
,
concentrated solar radiation
,
energy conversion
,
energy conversion applications
,
Energy Efficiency
,
Energy Generation & Storage
,
Energy Generation, Transmission, or Storage
,
energy management
,
Energy Management System
,
energy-efficient cooling
,
heat dissipation
,
infrared (IR) radiation
,
infrared-reflectance
,
Paint
,
paint architecture
,
passive daytime radiative cooling (PDRC)
,
phot
other
mal materials
,
pigmented coating
,
real-time thermal management
,
Renewable Energy
,
Renewable energy sources
,
solar reflectance
,
thermal control
,
thermal control materials
,
Thermal Energy Storage
,
thermal management
,
thermal management systems
,
thermal metamaterials
,
thermal stability
,
ultraviolet reflectance
,
visible reflectance
Category(s):
Materials
,
Materials > Functional Materials
,
Materials > Nanotechnology
,
Energy & Environment
,
Energy & Environment > Energy Transmission
,
Energy & Environment > Energy Efficiency
,
Chemical
,
Chemical > Coatings, Adhesives & Inks
,
Chemical > Industrial & Bulk Chemicals
,
Energy & Environment > Thermal
Method and Apparatus for Improving the Signal-To-Noise Ratio in Multi-Dimensional Magnetic Resonance Imaging Data (Case No. 2025-204)
Summary: UCLA researchers have developed a software-based denoising method that makes cardiac MRI images clearer and more reliable, enabling more accurate heart function measurements without requiring longer scan times. Background: Cardiac MRI is a powerful imaging tool for assessing heart health because it can provide detailed pictures of how the...
Published: 11/13/2025
|
Inventor(s):
Xiaodong Zhong
,
Shu-Fu Shih
,
Holden Wu
,
Kim-Lien Nguyen
Keywords(s):
2D ultrasound imaging
,
3D tissue imaging
,
3D ultrasound imaging
,
AI-guided medical imaging
,
AI-guided medical intervention
,
bioimaging
,
Biologic Medical Product
,
Biomedical Engineering
,
Cardiac Magnetic Resonance Imaging
,
Image Analysis
,
Imaging
,
Magnetic Resonance Imaging
,
Magnetic Resonance Imaging Carotid Artery Stenosis
,
Magnetic Resonance Imaging Hypoxia (Medical)
,
Magnetic Resonance Imaging Medical Physics
,
Magnetic Resonance Imaging Microangiopathy
,
Magnetic Resonance Imaging Pathology
,
Magnetic Resonance Imaging Spin Polarization
,
Magnetic Resonance Imaging Unmanned Aerial Vehicle
,
Medical artificial intelligence (AI)
,
Medical Device
,
medical device cardiac monitoring
,
Medical Devices and Materials
,
Medical diagnostics
,
Medical Imaging
Category(s):
Medical Devices > Cardiac
,
Medical Devices > Medical Imaging
,
Medical Devices > Medical Imaging > MRI
,
Software & Algorithms > Image Processing
,
Software & Algorithms
B Cell-Based Assay to Expand Antigen-Specific T Cells (UCLA Case No. 2025-288)
UCLA researchers from the Department of Medicine have developed a novel B cell-based assay to expand antigen-specific T cells, allowing for an efficient, patient-specific platform to generate tumor antigen-specific T cells. BACKGROUND: Adoptive T cell therapies have emerged as a promising strategy for cancer immun
other
apy, enabling the expansion of...
Published: 11/6/2025
|
Inventor(s):
Yuanyuan Tong
,
Willy Hugo
,
Maureen Su
,
Melissa Lechner
,
Robert Prins
Keywords(s):
Category(s):
Therapeutics > Oncology
,
Therapeutics > Immunology And Immun
other
apy
Aerodynamics-Informed Design Optimization of Vehicles with Machine Learning (Case No. 2025-083)
Intro Sentence: UCLA researchers from the Department of Mechanical and Aerospace Engineering have developed a machine-learning–guided aerodynamic optimization framework that accelerates the design of electric vehicles by coupling high-fidelity simulations with data-driven shape prediction. Background: Electric vehicle (EV) technologies have...
Published: 11/5/2025
|
Inventor(s):
Kunihiko Taira
,
Jonathan Tran
,
Kai Fukami
,
Daisuke Umehara
,
Kenta Inada
,
Yoshimichi Ono
,
Kenta Ogawa
Keywords(s):
Category(s):
Software & Algorithms
,
Software & Algorithms > AI Algorithms
,
Software & Algorithms > Artificial Intelligence & Machine Learning
,
Materials
,
Materials > Functional Materials
,
Energy & Environment
Silyl Ether Enables Chemoproteomic Interaction and Target Engagement (SEE-CITE) (UCLA Case No. 2024-194)
UCLA researchers from the Department of Biological Chemistry have developed a chemoproteomic platform for high-coverage, site-specific mapping of small-molecule–protein interactions using a cleavable silyl ether–based photoaffinity probe design. BACKGROUND: Small molecule drugs rely on specific and selective interactions with protein targets...
Published: 11/4/2025
|
Inventor(s):
Keriann Backus
Keywords(s):
Category(s):
Life Science Research Tools > Mass Spectrometry
,
Life Science Research Tools > Research Methods
,
Therapeutics > Oncology
Pancreas Cancer Immun
other
apy using Cationic Lipid and Polymer Nanocarriers for co-delivery of KRAS Neoantigens and STING or other immunomodulators to boost the Cancer Immunity Cycle and Treat Liver Metastasis (UCLA Case No. 2024-076)
UCLA researchers have developed a translational immun
other
apy platform that leverages nanoparticle-based delivery of tumor-associated signals and immune-stimulatory molecules to drive localized immune activation in metastatic pancreatic cancer. This approach is designed to initiate de novo immune priming and recondition the tumor microenvironment in...
Published: 10/29/2025
|
Inventor(s):
Andre Nel
Keywords(s):
Category(s):
Therapeutics > Oncology
,
Therapeutics > Immunology And Immun
other
apy
,
Therapeutics > Vaccines
,
Platforms > Drug Delivery
Histone H1 as a Therapeutic Target for Fibrosis (UCLA Case No. 2023-148)
UCLA researchers from the David Geffen School of Medicine have identified linker histone H1 as a critical regulator of pathologic gene expression and cellular mechanics, establishing its potential role as a therapeutic target for the treatment of fibrosis. BACKGROUND: Heart failure affects ~6 million Americans and has a 5-year survival rate of ~50%...
Published: 10/29/2025
|
Inventor(s):
Thomas Vondriska
Keywords(s):
Category(s):
Therapeutics > Cardiovascular
Mucus Targeting Particles (MTPs) Technology for Sustained Drug Delivery Applications (UCLA Case No. 2020-809)
UCLA researchers in the Department of Chemical and Biomolecular Engineering have developed a robust nanoparticle technology for effective, sustained-release ocular drug delivery. BACKGROUND: Topically applied therapeutics are the common mode of delivery for treating ocular diseases, ranging from chronic conditions like glaucoma to acute inflammation...
Published: 10/24/2025
|
Inventor(s):
Nasim Annabi
,
Shima Gholizadeh
,
Reza Dana
Keywords(s):
Category(s):
Therapeutics > Ophthalmology
,
Materials > Nanotechnology
,
Platforms > Drug Delivery
1
2
3
4
5
6
7
8
9
10
...